Assessing the Influence of the Health System on Access to Cervical Cancer Prevention, Screening, and Treatment Services at Public Health Centers in Addis Ababa, Ethiopia

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2024 May 31

PMID 38820249

Authors

Kemal Hussein

Gilbert Kokwaro

Francis Wafula

Getnet Mitike Kassie

Affiliations

Soon will be listed here.

Abstract

Background: Cervical cancer is the second leading cause of cancer death among Ethiopian women. This study aimed to assess the influence of the health system on access to cervical cancer prevention, screening, and treatment services at public health centers in Addis Ababa, Ethiopia.

Methods: This study used a cross-sectional survey design and collected data from 51 randomly selected public health centers in Addis Ababa. Open Data Kit was used to administer a semi-structured questionnaire on Android tablets, and SPSS version 26 was used to analyze the descriptive data.

Results: In the study conducted at 51 health centers, cervical cancer prevention and control services achieved 61% HPV vaccination for girls, 79% for cervical cancer awareness messages, 80% for precancer lesion treatment, and 71% for cervical screening of women. All health centers were performing cervical screening mostly through visual inspection with acetic acid due to the inconsistent availability of HPV DNA tests and the lack of Pap smear tests. In 94% of health centers, adequate human resources were available. However, only 78% of nurses, 75% of midwives, 35% of health officers, and 49% of health extension workers received cervical cancer training in the 24 months preceding the study. Women had provider choices in only 65% of health centers, and 86% of the centers lacked electronic health records. In 41% of the health centers, the waiting time was 30 minutes or longer. About 88% and 90% of the facilities lacked audio and video cervical cancer messages, respectively.

Conclusion: This study revealed that the annual cervical cancer screening achievement was on track to fulfill the WHO's 90-70-90 targets by 2030. We recommend that decision-makers prioritize increasing HPV vaccination rates, enhancing messaging, reducing wait times, and implementing electronic health records to improve access to cervical cancer services in Addis Ababa.

References

Holme F, Jeronimo J, Maldonado F, Camel C, Sandoval M, Martinez-Granera B . Introduction of HPV testing for cervical cancer screening in Central America: The Scale-Up project. Prev Med. 2020; 135:106076. PMC: 7218710. DOI: 10.1016/j.ypmed.2020.106076. View

Adedimeji A, Ajeh R, Pierz A, Nkeng R, Ndenkeh J, Fuhngwa N . Challenges and opportunities associated with cervical cancer screening programs in a low income, high HIV prevalence context. BMC Womens Health. 2021; 21(1):74. PMC: 7890622. DOI: 10.1186/s12905-021-01211-w. View

Burrowes S, Holcombe S, Leshargie C, Hernandez A, Ho A, Galivan M . Perceptions of cervical cancer care among Ethiopian women and their providers: a qualitative study. Reprod Health. 2022; 19(1):2. PMC: 8725313. DOI: 10.1186/s12978-021-01316-3. View

Kassie A, Abate B, Kassaw M, Aragie T, Geleta B, Shiferaw W . Impact of knowledge and attitude on the utilization rate of cervical cancer screening tests among Ethiopian women: A systematic review and meta-analysis. PLoS One. 2020; 15(12):e0239927. PMC: 7723289. DOI: 10.1371/journal.pone.0239927. View

Atnafu T, Daka D, Fufa Debela T, Seboka Ergiba M . Women's Satisfaction with Cervical Cancer Screening Services and Associated Factors in Maternal Health Clinics of Jimma Town Public Health Facilities, Southwest Ethiopia. Cancer Manag Res. 2021; 13:7685-7696. PMC: 8504707. DOI: 10.2147/CMAR.S327369. View

Muriithi F, Banke-Thomas A, Gakuo R, Pope K, Coomarasamy A, Gallos I . Individual, health facility and wider health system factors contributing to maternal deaths in Africa: A scoping review. PLOS Glob Public Health. 2023; 2(7):e0000385. PMC: 10021542. DOI: 10.1371/journal.pgph.0000385. View

Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B . Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 2022; 11(2):e197-e206. PMC: 9848409. DOI: 10.1016/S2214-109X(22)00501-0. View

Seyoum A, Assefa N, Gure T, Seyoum B, Mulu A, Mihret A . Prevalence and Genotype Distribution of High-Risk Human Papillomavirus Infection Among Sub-Saharan African Women: A Systematic Review and Meta-Analysis. Front Public Health. 2022; 10:890880. PMC: 9304908. DOI: 10.3389/fpubh.2022.890880. View

Bogale A, Teklehaymanot T, Ali J, Kassie G, Medhin G, Baye A . Comparison of self-collected versus clinician collected cervicovaginal specimens for detection of high risk human papillomavirus among HIV infected women in Ethiopia. BMC Womens Health. 2022; 22(1):360. PMC: 9434869. DOI: 10.1186/s12905-022-01944-2. View

10.

Vahedpoor Z, Behrashi M, Khamehchian T, Abedzadeh-Kalahroudi M, Moravveji A, Mohmadi-Kartalayi M . Comparison of the diagnostic value of the visual inspection with acetic acid (VIA) and Pap smear in cervical cancer screening. Taiwan J Obstet Gynecol. 2019; 58(3):345-348. DOI: 10.1016/j.tjog.2019.03.010. View

11.

Dereje N, Addissie A, Worku A, Assefa M, Abraha A, Tigeneh W . Extent and Predictors of Delays in Diagnosis of Cervical Cancer in Addis Ababa, Ethiopia: A Population-Based Prospective Study. JCO Glob Oncol. 2020; 6:277-284. PMC: 7055465. DOI: 10.1200/JGO.19.00242. View

12.

Memirie S, Kifle Habtemariam M, Asefa M, Deressa B, Abayneh G, Tsegaye B . Estimates of Cancer Incidence in Ethiopia in 2015 Using Population-Based Registry Data. J Glob Oncol. 2018; 4:1-11. PMC: 6223441. DOI: 10.1200/JGO.17.00175. View

13.

Tapera O, Dreyer G, Nyakabau A, Kadzatsa W, Stray-Pedersen B, Hendricks S . Model strategies to address barriers to cervical cancer treatment and palliative care among women in Zimbabwe: a public health approach. BMC Womens Health. 2021; 21(1):180. PMC: 8077905. DOI: 10.1186/s12905-021-01322-4. View

14.

Awedew A, Asefa Z, Belay W . National Burden and Trend of Cancer in Ethiopia, 2010-2019: a systemic analysis for Global burden of disease study. Sci Rep. 2022; 12(1):12736. PMC: 9325704. DOI: 10.1038/s41598-022-17128-9. View

15.

Huy N, Minh Tam L, Tram N, Thuan D, Vinh T, Thanh C . The value of visual inspection with acetic acid and Pap smear in cervical cancer screening program in low resource settings - A population-based study. Gynecol Oncol Rep. 2018; 24:18-20. PMC: 5842293. DOI: 10.1016/j.gore.2018.02.004. View

16.

Lott B, Halkiyo A, Kassa D, Kebede T, Dedefo A, Ehiri J . Health workers' perspectives on barriers and facilitators to implementing a new national cervical cancer screening program in Ethiopia. BMC Womens Health. 2021; 21(1):185. PMC: 8090515. DOI: 10.1186/s12905-021-01331-3. View

17.

Tzelepis F, Sanson-Fisher R, Zucca A, Fradgley E . Measuring the quality of patient-centered care: why patient-reported measures are critical to reliable assessment. Patient Prefer Adherence. 2015; 9:831-5. PMC: 4484696. DOI: 10.2147/PPA.S81975. View

18.

Ararsa T, Tadele N, Ayalew Y, Gela D . Knowledge towards cervical cancer screening and associated factors among urban health extension workers at Addis Ababa, Ethiopia: facility based cross-sectional survey. BMC Cancer. 2021; 21(1):224. PMC: 7934429. DOI: 10.1186/s12885-021-07952-z. View

19.

Kasim J, Kalu A, Kamara B, Alema H . Cervical Cancer Screening Service Utilization and Associated Factors among Women in the Shabadino District, Southern Ethiopia. J Cancer Epidemiol. 2020; 2020:6398394. PMC: 7354647. DOI: 10.1155/2020/6398394. View

20.

Haileselassie W, Mulugeta T, Tigeneh W, Kaba M, Labisso W . The Situation of Cancer Treatment in Ethiopia: Challenges and Opportunities. J Cancer Prev. 2019; 24(1):33-42. PMC: 6453587. DOI: 10.15430/JCP.2019.24.1.33. View